Kit for Drug-Containing Nanoparticles and Composition for Drug Delivery

ChangeBridge: Patent Apps - Pharma (A61K)

Detected March 26th, 2026

Summary

The USPTO has published a new patent application (US20260083682A1) by SAMYANG HOLDINGS CORPORATION for a kit and composition for constructing drug-containing nanoparticles for enhanced drug delivery. The application details a method utilizing cationic compounds and anionic polymers to improve cellular drug delivery efficiency.

View original document View source feed page

What changed

This document is a published patent application (US20260083682A1) from the USPTO, filed by SAMYANG HOLDINGS CORPORATION. It describes a kit and nanoparticle composition designed to improve the efficiency of cellular drug delivery. The invention utilizes nanoparticles incorporating a cationic compound and an anionic polymer compound with at least one acidic functional group to achieve this enhanced delivery.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it represents a new development in drug delivery technology that pharmaceutical companies and medical device makers may wish to monitor for potential future licensing or competitive landscape analysis. The filing date was July 26, 2023.

Source document (simplified)

← USPTO Patent Applications

KIT FOR MANUFACTURE OF DRUG-CONTAINING NANOPARTICLES AND NANOPARTICLE COMPOSITION FOR DRUG DELIVERY

Application US20260083682A1 Kind: A1 Mar 26, 2026

Assignee

SAMYANG HOLDINGS CORPORATION

Inventors

Go Eun Kim, Kyu Jin KYUNG, So Young KIM, Joung Pyo NAM, So Jin LEE, Jong Min PARK, Won II SEO

Abstract

The present invention relates to a kit for construction of drug-containing nanoparticles and a nanoparticle composition for drug delivery. More specifically, the present invention concerns a kit for construction of drug-containing nanoparticles and a nanoparticle composition for drug delivery, each designed to increase the efficiency of cellular drug delivery by utilizing nanoparticles that include a cationic compound and an anionic polymer compound with at least one acidic functional group.